AthemBio

AthemBio is a Durham, North Carolina-based bioprocessing technology company dedicated to reducing the cost of biologics and accelerating the development of life-saving therapies.

We tackle the critical barrier that limits patient access to medicine: the excessive cost of biologics. Our innovative platforms, including CORIgâ, machroSâ, and cRUSHâ, are designed to simplify bioprocessing workflows, reduce manufacturing expenses, and improve therapeutic outcomes.

At AthemBio, we collaborate with a diverse range of customers – from startups and academia to large CDMOs and biopharma leaders – to deliver tailored solutions that address their unique challenges. We are committed to being your partner in achieving bioprocessing success and cost-efficiency, ultimately contributing to more affordable and accessible healthcare for all. We focus on continuous, single-use technologies that dramatically reduce footprint and processing time.

Our core technologies – CORIg, machroS, and cRUSH – represent a paradigm shift in bioprocessing, enabling faster development cycles, increased yields, and significant cost savings. We are proud to be a leader in driving innovation and accessibility within the biopharmaceutical industry.